Inhaled antibiotics beyond aminoglycosides, polymyxins and aztreonam: A systematic review - PubMed

Review

Inhaled antibiotics beyond aminoglycosides, polymyxins and aztreonam: A systematic review

Matthew E Falagas et al. Int J Antimicrob Agents. 2015 Mar.

Abstract

We sought to evaluate published evidence regarding clinical or microbiological outcomes related to the use of inhaled antibiotics other than aminoglycosides, polymyxins and aztreonam. A systematic search of PubMed and Scopus databases as well as bibliographies of eligible articles was performed. In total, 34 eligible studies were identified. Among several inhaled β-lactams, ceftazidime was used with varying success in the prevention and treatment of ventilator-associated pneumonia (VAP) and improved clinical outcomes in chronic Pseudomonas aeruginosa lower respiratory tract infections (LRTIs) in patients with cystic fibrosis (CF) or bronchiectasis. Inhaled vancomycin, as an adjunctive therapy, was effective in treating Gram-positive VAP, whilst inhaled levofloxacin, ciprofloxacin and an inhaled combination of fosfomycin and tobramycin were associated with improved microbiological or clinical outcomes in chronic LRTI in patients with CF or bronchiectasis. In conclusion, published evidence is heterogeneous with regard to antibiotics used, studied indications, patient populations and study designs. Therefore, although the currently available data are encouraging, no safe conclusion regarding the effectiveness and safety of the drugs in question can be reached.

Keywords: Aerosolised antibiotics; Hospital-acquired pneumonia; Nebulised antibiotics; Nosocomial pneumonia.

Similar articles

• Aerosolized Antibiotics.

  Restrepo MI, Keyt H, Reyes LF. Restrepo MI, et al. Respir Care. 2015 Jun;60(6):762-1; discussion 771-3. doi: 10.4187/respcare.04208. Respir Care. 2015. PMID: 26070573 Review.

• Evidence for the efficacy of aztreonam for inhalation solution in the management of Pseudomonas aeruginosa in patients with cystic fibrosis.

  Hansen C, Skov M. Hansen C, et al. Ther Adv Respir Dis. 2015 Feb;9(1):16-21. doi: 10.1177/1753465814561624. Ther Adv Respir Dis. 2015. PMID: 25471692 Review.

• Inhaled antibiotics for lower airway infections.

  Quon BS, Goss CH, Ramsey BW. Quon BS, et al. Ann Am Thorac Soc. 2014 Mar;11(3):425-34. doi: 10.1513/AnnalsATS.201311-395FR. Ann Am Thorac Soc. 2014. PMID: 24673698 Free PMC article. Review.

• Inhaled colistin for lower respiratory tract infections.

  Antoniu SA, Cojocaru I. Antoniu SA, et al. Expert Opin Drug Deliv. 2012 Mar;9(3):333-42. doi: 10.1517/17425247.2012.660480. Epub 2012 Feb 14. Expert Opin Drug Deliv. 2012. PMID: 22332963 Review.

• Comparing inhaled colistin with inhaled fosfomycin/tobramycin as an adjunctive treatment for ventilator-associated pneumonia: An open-label randomized controlled trial.

  Hakamifard A, Torfeh Esfahani AA, Homayouni A, Khorvash F, Ataei B, Abbasi S. Hakamifard A, et al. Clin Respir J. 2023 Apr;17(4):295-302. doi: 10.1111/crj.13594. Epub 2023 Feb 12. Clin Respir J. 2023. PMID: 36775964 Free PMC article. Clinical Trial.

Cited by

• Biopharmaceutical Characterization of Nebulized Antimicrobial Agents in Rats. 4. Aztreonam.

  Marchand S, Grégoire N, Brillault J, Lamarche I, Gobin P, Couet W. Marchand S, et al. Antimicrob Agents Chemother. 2016 Apr 22;60(5):3196-8. doi: 10.1128/AAC.00165-16. Print 2016 May. Antimicrob Agents Chemother. 2016. PMID: 26926626 Free PMC article.

• Evaluation of liposomal ciprofloxacin formulations in a murine model of anthrax.

  Stratilo CW, Jager S, Crichton M, Blanchard JD. Stratilo CW, et al. PLoS One. 2020 Jan 24;15(1):e0228162. doi: 10.1371/journal.pone.0228162. eCollection 2020. PLoS One. 2020. PMID: 31978152 Free PMC article.

• Novel antibiotic combinations proposed for treatment of Burkholderia cepacia complex infections.

  El-Halfawy OM, Naguib MM, Valvano MA. El-Halfawy OM, et al. Antimicrob Resist Infect Control. 2017 Nov 25;6:120. doi: 10.1186/s13756-017-0279-8. eCollection 2017. Antimicrob Resist Infect Control. 2017. PMID: 29204272 Free PMC article.

• [Infections due to multidrug-resistant pathogens : Pathogens, resistance mechanisms and established treatment options].

  Richter DC, Brenner T, Brinkmann A, Grabein B, Hochreiter M, Heininger A, Störzinger D, Briegel J, Pletz M, Weigand MA, Lichtenstern C. Richter DC, et al. Anaesthesist. 2019 Oct;68(10):711-730. doi: 10.1007/s00101-019-00645-0. Anaesthesist. 2019. PMID: 31555833 Review. German.

• Antioxidant and Pro-Oxidant Properties of Selected Clinically Applied Antibiotics: Therapeutic Insights.

  Maliar T, Blažková M, Polák J, Maliarová M, Ürgeová E, Viskupičová J. Maliar T, et al. Pharmaceuticals (Basel). 2024 Sep 24;17(10):1257. doi: 10.3390/ph17101257. Pharmaceuticals (Basel). 2024. PMID: 39458897 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • ClinicalKey
  • Elsevier Science

• Medical

  • MedlinePlus Health Information